Omni Partners US’s Lydall, Inc. LDL Stock Holding History

Omni Partners US’s Portfolio LDL Stock Details LDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$14.2M	Buy	228,416 +60,127	+36%	+$3.7M	0.73%	19
2021 Q2	$10.2M	Buy	+168,289	New	+$6.47M	0.45%	24

Other funds holding LDL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Omni Partners US's LDL Position: Q3 2021 in Review

Omni Partners US increased its Lydall, Inc. (LDL) stake by 36% in Q3 2021, buying an estimated $3.7M and bringing the position to 228,416 shares worth $14.2M. The position accounts for 0.73% of the portfolio, ranked #19.

Omni Partners US first reported a position in LDL in Q2 2021 and has held it in 2 quarters since. 158 funds tracked by Wall St. Rank hold LDL as of Q3 2021.

Omni Partners US held 228,416 shares of Lydall, Inc. worth $14.2M as of Q3 2021.
Omni Partners US bought 60,127 Lydall, Inc. shares in Q3 2021, an estimated $3.7M.
Lydall, Inc. made up 0.73% of Omni Partners US's portfolio in Q3 2021, its #19 holding.
Omni Partners US first reported a position in Lydall, Inc. in Q2 2021 and has held it in 2 quarters since.
158 funds tracked by Wall St. Rank held Lydall, Inc. as of Q3 2021.

Based on Omni Partners US's 13F filing for Q3 2021, filed 15 Nov 2021.